Cardinal Health (Dublin, Ohio) announced that it will integrate radio frequency identification (RFID) technology into the operations of its Sacramento, Calif. pharmaceutical distribution center by Fall 2007, to prepare for California’s pedigree legislation. This wide-ranging legislation requires all drugs distributed within the state be tracked and traced as they move throughout the supply chain.
This move is part of Cardinal Health’s ongoing efforts to protect the safety and efficiency of the nation’s drug supply.
The announcement comes just months after Cardinal Health shared the results of its RFID pilot program, which was the health-care industry’s first end-to-end test of RFID in a real-world setting. Data collected from the pilot confirmed that RFID technology using UHF as a single frequency is a feasible solution to track and trace the possession of pharmaceuticals at the unit, case and pallet levels. The pilot also confirmed that RFID technology offers significant promise to provide an added layer of safety within the pharmaceutical supply chain, by enabling item-level pedigrees to be tracked and traced as they pass from manufacturer to wholesaler to pharmacy.
The recently passed state legislation in California requires pharmaceutical manufacturers to originate item-level pedigrees for drugs distributed within the state’s borders. This legislation also requires companies within the pharmaceutical supply chain (including companies that distribute drugs, like Cardinal Health) to update item-level drug pedigrees upon each change of ownership.
Cardinal Health operates dozens of pharmaceutical distribution centers nationwide. The company will start implementing RFID technology in its Sacramento, Calif. distribution center, as a means to receive and produce the electronic drug pedigrees needed to meet the requirements of the California legislation.
“While the Sacramento project is designed to support the pedigree legislation in California, it’s also an extension of the end-to-end RFID pilot that we completed last year,” said Steve Inacker, executive vice president of Global Supplier Services for Cardinal Health. “We look forward to leveraging this work to further validate the effectiveness and viability of RFID technology in real-world settings, should it be adopted as an industry standard.”
As part of this effort, Cardinal Health will also leverage the new data, made available by RFID technology, to identify efficiency opportunities in key areas including returns and order accuracy, which can deliver value to the entire pharmaceutical supply chain.
